Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1/2 2 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 718 Lung Neoplasms 309 Small Cell Lung Carcinoma 110 Neoplasms 42 Adenocarcinoma of Lung 40 Neoplasm Metastasis 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 22 Brain Neoplasms 21 Carcinoma 19 Breast Neoplasms 18 Lung Diseases 15 NSCLC 14 Mesothelioma, Malignant 14 Thoracic Neoplasms 13 Adenocarcinoma, Bronchiolo-Alveolar 13 Prostatic Neoplasms 11 Pleural Effusion, Malignant 10 Non-Squamous Non-Small Cell Lung Cancer 10 Mesothelioma 10 Cachexia 10 Respiratory Tract Neoplasms 9 Pain 9 Bronchial Neoplasms 9 Respiratory Tract Diseases 8 Carcinoma, Squamous Cell 8 Carcinoma, Bronchogenic 8 Adenocarcinoma 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Colonic Neoplasms 7

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-Small Cell Lung Cancer Metastatic × Thoracic × Clear all

NCT03469960 2025-11-18

DICIPLE

Intergroupe Francophone de Cancerologie Thoracique

Phase 3 Completed

Non-Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡